Product information
From Health Canada
Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.
Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.
Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.
- Natural Product Number (NPN):
- 80144338
- Market status:
- Not Marketed
- Licence Status:
- Active
- Brand name(s):
-
Harmonia
;
Harmonia Women's Health ;
Harmonia Women's Health Support - Licence holder:
- Isagenix Canada ULC
- Dosage Form:
- Capsule
- Recommended route of administration:
-
Oral
| Sub population (Sub Pop.) | Quantity (Qty) | Frequency (Freq.) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sub Pop. | Age | Min. | Max. | UoM Footnote1 Age | Qty | Min. | Max. | UoM Qty | Freq. | Min. | Max. | UoM Freq. |
| Women | 19 | year(s) | 1.0 | capsule | 2 | daily | ||||||
- Recommended use or purpose:
- Helps to relieve the symptoms associated with menopause such as hot flashes, night sweats, paresthesia, insomnia, nervousness, vertigo, fatigue, rheumatic pain and vaginal dryness. Helps support healthy mood balance during menopause. Helps to support healthy mood balance. Source of probiotics. Helps restore and maintain healthy vaginal flora. Helps maintain healthy vaginal flora.
- Risk Information:
- Cautions and Warnings
- Ask a health care practitioner if symptoms persist or worsen. Ask a health care practitioner before use if you have fever, vomiting, bloody diarrhoea, severe abdominal pain, or a bleeding disorder, or if you are taking blood thinners such as anticoagulants, antiplatelets or aspirin, or are taking blood pressure medication. When using this product you may experience nervousness, gastrointestinal discomfort or headaches. Stop use and ask a health care practitioner if symptoms of digestive upset (e.g. diarrhea) occur, worsen and/or persists beyond 3 days. Ask your health care practitioner before use if you suffer from any psychological disorder and/or condition such as anxiety or depression, unstable medical illness or seizure disorder within the past year, history of multiple drug reaction, major psychiatric disorder, suicidal ideation or intent, or if you use psychoactive drugs.
- Contra-Indications
- Do not use this product if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment), or if you are pregnant or breastfeeding.
| Medicinal ingredients | Quantity (Qty) | Extract | Potency |
|---|---|---|---|
| Angelica gigas |
90.0 mg
|
5
:
1
DHE: 450 mg Dry |
|
| Crocus sativus |
15.0 mg
|
10
:
1
DHE: 150 mg Dry |
2.0
%
Safranal |
| Cynanchum wilfordii |
83.5 mg
|
5
:
1
DHE: 417.5 mg Dry |
|
| Lacticaseibacillus rhamnosus |
500.0 million cfu
|
||
| Limosilactobacillus reuteri |
500.0 million cfu
|
||
| Phlomis umbrosa |
83.5 mg
|
5
:
1
DHE: 417.5 mg Dry |
- List of non-medicinal ingredients:
-
- Hypromellose
- Magnesium stearate
- Maltodextrin
- Microcrystalline cellulose
- Silicon dioxide
- Stearic acid
- Date of licensing:
- 2025-09-23
- Revised date of licence:
Application information
Related information
Contact us
For technical support or if you have general questions concerning the content of this database, please contact the Natural Health Products Directorate (NHPD).